Targeting the Cell Death-Survival Equation
Authors:
Open Access
- 15 December 2007
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (24) , 7250-7253
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Is Cell Death a Critical End Point for Anticancer Therapies or Is Cytostasis Sufficient?Clinical Cancer Research, 2007
- The Challenge of Drugging Undruggable Targets in Cancer: Lessons Learned from Targeting BCL-2 Family MembersClinical Cancer Research, 2007
- The Roles of Therapy-Induced Autophagy and Necrosis in Cancer TreatmentClinical Cancer Research, 2007
- Applying the discovery of the Philadelphia chromosomeJournal of Clinical Investigation, 2007
- Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in Human Liver Preservation InjuryAmerican Journal of Transplantation, 2006
- Promoting apoptosis as a strategy for cancer drug discoveryNature Reviews Cancer, 2005
- Evasion of the p53 tumour surveillance network by tumour-derived MYC mutantsNature, 2005
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic miceNature, 1985
- Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18Cell, 1985